Home Healthcare Market

Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes) & Region - Global Forecast to 2027

Report Code: MD 1160 Nov, 2022, by marketsandmarkets.com

The global home healthcare market, in terms of revenue, was estimated to be worth $226 billion in 2022 and is poised to reach $340.2 billion by 2027, growing at a CAGR of 8.5% from 2022 to 2027. Growth of this market is driven by the increasing incidence of chronic ailments, and emerging Asian countries are also expected to offer substantial growth opportunities for players in the market.

Home Healthcare Market

To know about the assumptions considered for the study, Request for Free Sample Report

Home Healthcare Market Dynamics

Driver: Rapid growth in the elderly population and rising incidence of chronic diseases

Because an ageing population is more susceptible to chronic diseases, the growth of this population segment will increase demand for healthcare and significantly increase the strain on governments and health systems, benefiting the global market. Healthcare provided at home cuts down on needless hospital admissions and readmissions and the time and money spent commuting to see medical specialists.

Opportunity: rising focus on telehealth

Home healthcare practitioners can still have an influence even when they are not physically there because of telehealth. It makes it possible to monitor a patient continuously and foresee future crises before they happen. Remote patient monitoring, virtual medical, health, and educational services are all included in the field of telehealth. Nurses or doctors can use audio-visual technologies during virtual sessions to assess a patient's condition and choose the best course of action, which may include giving care, writing a prescription, or, in some situations, sending the patient for additional treatment. Telehealth is increasingly beneficial to patients for these reasons.

Restraints: Limited insurance coverage

In most North American nations, home healthcare services are covered by insurance; however, this insurance coverage is only extended to Medicare-certified home healthcare organizations. Insurance does not pay for equipment used for remote monitoring, telemetry, rehabilitation, or multi-parameter monitoring. Insurance coverage for this equipment is inconsistent in both European and North American nations. In-home healthcare treatments for the elderly and chronic illnesses are not reimbursed by insurance companies in Asian nations like India; instead, they are only covered if they are post-hospitalization therapies.

Challenges: a scarcity of homecare workers

Home healthcare is a thriving industry with a high demand for workers. Personal care aides and home health aides are among the top 10 home healthcare jobs, according to the US Bureau of Labor Statistics' employment predictions for the period 2014–2024. Additionally, between 2021 and 2031, 924,000 personal care and home health aides are expected to be in demand. As a result, to meet the growing demand, home healthcare providers need to locate some 924,000 new patients (source: US Bureau of Labor Statistics).

The therapeutic products segment accounted for the largest share of the home healthcare market by products.

By products, the market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. The therapeutic products accounted for the largest share in 2021, mainly due to the rising incidence of chronic ailments, such as sleep and respiratory disorders and kidney diseases, which has increased the demand for home healthcare therapeutic equipment.

Skilled nursing services accounted for the largest share of the home healthcare market.

By services, the market is segmented into skilled nursing services, rehabilitation therapy services, hospice and palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. Factors such as the increasing demand for homecare services are driving the growth of the market.

Other indications accounted for the largest share of the home healthcare market by indication.

By indications, the market is segmented into cancer, respiratory diseases, movement disorders, cardiovascular diseases and hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications. The rising incidence of kidney and sleep disorders is one of the factors driving market growth.

North America accounted for the largest region of the home healthcare market, by regions.

By regions, the market is segmented into four major regions: North America, Europe, Asia Pacific, and the Rest of the World. The large share of North America in the global market is attributed to the rising incidence of chronic ailments and its superior healthcare infrastructure. However, the Asia-Pacific market is estimated to grow at the highest CAGR during the forecast period. Growth in the Asia Pacific market is driven primarily by the high incidence of chronic diseases and increasing healthcare costs.

Home Healthcare Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Home healthcare market players are Fresenius SE & Co. KGaA (Germany), Linde, Plc (Ireland), F.Hoffmann-La Roche, Ltd. (Switzerland), A&D Company, Limited (Japan), Bayada Home Health Care (US), Invacare Corporation (US), Abbott (US), Amedisys (US), ResMed, Inc. (US), LHC Group, Inc. (US), Omron Corporation (Japan), Koninkluke Philips N.V. (Netherlands), GE Healthcare (US), Drive Devilbiss Healthcare (UK), Hamilton Medical (Switzerland), Sunrise Medical (Germany), Roma Medical (UK), Caremax Rehabilitation Equipment Co., Ltd. (China), Vitalograph (UK), Advita Pflegedienst Gmbh (Germany), Renafan Gmbh (Germany), ADMR (France), Apex Medical Corp. (Taiwan), Contec Medical Systems Co., Ltd. (China), Löwenstein Medical Technology Gmbh + Co., KG. (Germany), B. Braun Melsungen Ag (Germany), Baxter International, Inc. (US), Allied Healthcare Products, Inc. (US), Medline Industries, Inc. (US), and Advin Health Care (India).

Home Healthcare Market Report Scope

Report Metric

Details

Market Revenue in 2022

$226 billion

Estimated Value by 2027

$340.2 billion

Growth Rate

poised to grow at a CAGR of 8.5%

Largest Share Segments

Therapeutic products, Skilled nursing services, other indications

Market Report Segmentation

Product, Service, Indication, and region

Growth Drivers

  • Rapid growth in elderly population and rising incidence of chronic diseases
  • Rising R&D investments
  • Growing need for cost-effective healthcare delivery due to rising costs
  • Increased preference for personalized care

Growth Opportunities

  • Rising focus on telehealth
  • Untapped developing regions
  • Growing demand for home-use therapeutic devices
  • Growing demand for home sleep apnea tests
  • Rising preference for home hemodialysis treatment

Geographies covered

North America, Europe, Asia Pacific, and Rest of the World

This research report categorizes the home healthcare market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Therapeutic Products
  • Testing, Screening, and Monitoring Products
  • Mobility Care Products

By Service

  • Skilled Nursing
  • Rehabilitation Therapy
  • Hospice & Palliative Care
  • Unskilled Care
  • Respiratory Therapy
  • Infusion Therapy
  • Pregnancy Care

By Indication

  • Cancer
  • Respiratory Diseases
  • Movement Disorders
  • Cardiovascular Diseases & Hypertension
  • Pregnancy
  • Wound Care
  • Diabetes
  • Hearing Disorders
  • Other Indications

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World

Recent Developments:

  • In August 2022, Fresenius Medical Care North America (FMCNA) acquired InterWell Health Brand (US) to gain expertise in kidney care and value-based contracting and performance.
  • In August 2022, Contessa (US) partnered with Mount Sinai Health System (US) to offer a full continuum of home-based care that includes home health, hospitalisation at home, rehabilitation at home (in lieu of care at a skilled nursing facility), and palliative care at home.
  • To transform the manual wheelchair, Invacre Corporation (US) introduced the Next Generation e-fix eco Power Assist Device in July 2022.

Frequently Asked Questions (FAQ)

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 34)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
          TABLE 1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE
    1.4 YEARS CONSIDERED
    1.5 CURRENCY CONSIDERED
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES
    1.8 LIMITATIONS

2 RESEARCH METHODOLOGY (Page No. - 39)
    2.1 RESEARCH DATA
           FIGURE 1 HOME HEALTHCARE MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    TABLE 2 KEY DATA FROM PRIMARY SOURCES
                    FIGURE 2 KEY INDUSTRY INSIGHTS
                    2.1.2.1 Breakdown of primary interviews
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (GLOBAL MARKET)
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: F. HOFFMANN-LA ROCHE LTD.
                    2.2.1.1 Growth forecast
                    2.2.1.2 CAGR projections
                                FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.2.2 TOP-DOWN APPROACH
                    FIGURE 8 GLOBAL MARKET: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS
    2.5 STUDY ASSUMPTIONS
    2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 50)
    FIGURE 10 HOME HEALTHCARE MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION)
    FIGURE 11 GLOBAL MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)
    FIGURE 12 GLOBAL MARKET, BY SERVICE, 2022 VS. 2027 (USD BILLION)
    FIGURE 13 GLOBAL MARKET, BY INDICATION, 2022 VS. 2027 (USD BILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 HOME HEALTHCARE MARKET OVERVIEW
          FIGURE 15 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
    4.2 ASIA PACIFIC: MARKET, BY PRODUCT (2021)
          FIGURE 16 THERAPEUTIC PRODUCTS ACCOUNTED FOR LARGEST MARKET SHARE
    4.3 GEOGRAPHIC GROWTH OPPORTUNITIES IN GLOBAL MARKET
          FIGURE 17 JAPAN AND CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
    4.4 GLOBAL MARKET: GEOGRAPHIC MIX
          FIGURE 18 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
    4.5 GLOBAL MARKET: DEVELOPED VS. EMERGING ECONOMIES
          FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH

5 MARKET OVERVIEW (Page No. - 58)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 20 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rapid growth in elderly population and rising incidence of chronic diseases
                                TABLE 3 GERIATRIC POPULATION, 2022 VS. 2050 (MILLION)
                    5.2.1.2 Rising R&D investments
                                TABLE 4 PRODUCT LAUNCHES
                    5.2.1.3 Growing need for cost-effective healthcare delivery due to rising costs
                    5.2.1.4 Increased preference for personalized care
           5.2.2 RESTRAINTS
                    5.2.2.1 Changing reimbursement policies
                    5.2.2.2 Limited insurance coverage
                    5.2.2.3 Patient safety concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising focus on telehealth
                    5.2.3.2 Untapped developing regions
                    5.2.3.3 Growing demand for home-use therapeutic devices
                    5.2.3.4 Growing demand for home sleep apnea tests
                    5.2.3.5 Rising preference for home hemodialysis treatment
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of home care workers
                    5.2.4.2 Lack of supporting infrastructure
    5.3 PRICING ANALYSIS
          TABLE 5 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS (2022)
          TABLE 6 AVERAGE SELLING PRICE OF HOME HEALTHCARE PRODUCTS (2022)
    5.4 PATENT ANALYSIS
           5.4.1 PATENT ANALYSIS FOR TEMPERATURE MONITORING DEVICES
                    5.4.1.1 Granted patent publication trends for temperature monitoring devices
                                FIGURE 21 PATENT PUBLICATION TRENDS (JANUARY 2012–DECEMBER 2021)
                    5.4.1.2 Insights: Jurisdiction and top applicant analysis
                                FIGURE 22 TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR TEMPERATURE MONITORING DEVICES (JANUARY 2012–DECEMBER 2021)
                                FIGURE 23 TOP PATENT APPLICANT COUNTRIES/REGIONS FOR TEMPERATURE MONITORING DEVICES (JANUARY 2012–DECEMBER 2021)
                                FIGURE 24 PATENT ANALYSIS FOR THERMOMETERS (JANUARY 2012–DECEMBER 2021)
           5.4.2 LIST OF KEY PATENTS
    5.5 VALUE CHAIN ANALYSIS
          FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
    5.6 SUPPLY CHAIN ANALYSIS
          FIGURE 26 GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM/MARKET MAP
          FIGURE 27 GLOBAL MARKET: ECOSYSTEM/MARKET MAP
           5.7.1 GLOBAL MARKET: ROLE IN ECOSYSTEM
    5.8 PORTER’S FIVE FORCES ANALYSIS
           5.8.1 PULSE OXIMETERS
                    TABLE 7 PORTER’S FIVE FORCES ANALYSIS FOR THE PULSE OXIMETERS MARKET
                    5.8.1.1 Threat of new entrants
                    5.8.1.2 Threat of substitutes
                    5.8.1.3 Bargaining power of suppliers
                    5.8.1.4 Bargaining power of buyers
                    5.8.1.5 Degree of competition
           5.8.2 HEARING AIDS
                    TABLE 8 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET
                    5.8.2.1 Threat of new entrants
                    5.8.2.2 Threat of substitutes
                    5.8.2.3 Bargaining power of buyers
                    5.8.2.4 Bargaining power of suppliers
                    5.8.2.5 Degree of competition
    5.9 REGULATORY LANDSCAPE
          TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 13 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.9.1 NORTH AMERICA
                    5.9.1.1 US
                                TABLE 14 US FDA: CLASSIFICATION OF MEDICAL DEVICES
                                TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                                FIGURE 28 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
                    5.9.1.2 Canada
                                TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                                FIGURE 29 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA
           5.9.2 EUROPE
                    FIGURE 30 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES
           5.9.3 ASIA PACIFIC
                    5.9.3.1 Japan
                                 TABLE 17 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES
                    5.9.3.2 China
                                 TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.9.3.3 India
    5.1 TRADE ANALYSIS
           5.10.1 TRADE ANALYSIS FOR BLOOD PRESSURE MONITORS
                     TABLE 19 IMPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION)
                     TABLE 20 EXPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION)
    5.11 TECHNOLOGY ANALYSIS
    5.12 KEY CONFERENCES & EVENTS IN 2022–2023
           TABLE 21 GLOBAL MARKET: CONFERENCES & EVENTS
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           FIGURE 31 REVENUE SHIFT IN HOME HEALTHCARE
    5.14 KEY STAKEHOLDERS & BUYING CRITERIA
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
                     TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
           5.14.2 BUYING CRITERIA
                     FIGURE 33 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS
                     TABLE 23 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS

6 HOME HEALTHCARE MARKET, BY PRODUCT (Page No. - 98)
    6.1 INTRODUCTION
          TABLE 24 GLOBAL MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
    6.2 THERAPEUTIC PRODUCTS
          TABLE 25 KEY THERAPEUTIC PRODUCTS OFFERED
          TABLE 26 THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
          TABLE 27 THERAPEUTIC PRODUCTS MARKET, BY REGION, 2020–2027 (USD BILLION)
           6.2.1 DIALYSIS EQUIPMENT
                    6.2.1.1 Dialysis equipment to hold largest market share
                                TABLE 28 DIALYSIS EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.2 WOUND CARE PRODUCTS
                    6.2.2.1 Decreased costs and higher convenience and comfort to drive market growth
                                TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.3 IV EQUIPMENT
                    6.2.3.1 Accuracy and growing target disease prevalence to ensure market growth
                                TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.4 SLEEP APNEA THERAPEUTIC DEVICES
                    6.2.4.1 Increasing patient preference for home-based sleep tests to fuel market
                                TABLE 31 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.5 INSULIN DELIVERY DEVICES
                    6.2.5.1 High incidence of diabetes to drive market
                                TABLE 32 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.6 OXYGEN DELIVERY SYSTEMS
                    6.2.6.1 Technological advancements in oxygen therapy products to drive market
                                TABLE 33 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.7 INHALERS
                    6.2.7.1 High incidence of asthma to boost market
                                TABLE 34 INHALERS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.8 NEBULIZERS
                    6.2.8.1 Effectiveness over oral dosages to push preference for nebulizers
                                TABLE 35 NEBULIZERS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.9 VENTILATORS
                    6.2.9.1 Convenience and comfort to sustain end-user preference
                                TABLE 36 VENTILATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.10 OTHER THERAPEUTIC PRODUCTS
                    TABLE 37 OTHER THERAPEUTIC PRODUCTS, BY REGION, 2020–2027 (USD MILLION)
    6.3 TESTING, SCREENING, AND MONITORING PRODUCTS
          TABLE 38 KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED
          TABLE 39 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 40 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.1 BLOOD GLUCOSE MONITORS
                    6.3.1.1 Increasing prevalence of diabetes to drive market growth
                                TABLE 41 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.2 HEARING AIDS
                    6.3.2.1 High incidence of hearing impairment to drive market
                                TABLE 42 HEARING AIDS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.3 ACTIVITY MONITORS & WRISTBANDS
                    6.3.3.1 Increasing prevalence of chronic diseases to bolster demand for activity monitors
                                TABLE 43 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.4 BLOOD PRESSURE MONITORS
                    6.3.4.1 Rising patient population for hypertension and CVD to drive market
                                TABLE 44 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.5 ECG/EKG DEVICES
                    6.3.5.1 High prevalence of CVD to support demand
                                TABLE 45 ECG/EKG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.6 TEMPERATURE MONITORING DEVICES
                    6.3.6.1 Technological innovations and increasing awareness to drive growth
                                TABLE 46 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.7 HEART RATE MONITORS
                    6.3.7.1 Continuous cardiac parameter monitoring capabilities to drive demand
                                TABLE 47 HEART RATE MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.8 OVULATION & PREGNANCY TEST KITS
                    6.3.8.1 Privacy, convenience, accessibility, and quick results to drive market
                                TABLE 48 OVULATION & PREGNANCY TEST KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.9 FETAL MONITORING DEVICES
                    6.3.9.1 Remote-based care by portable fetal monitoring systems to drive market growth
                                TABLE 49 FETAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.10 PULSE OXIMETERS
                    6.3.10.1 Rising disease incidence and wide usage of pulse oximetry to ensure strong demand
                                TABLE 50 PULSE OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.11 HIV TEST KITS
                    6.3.11.1 Rising prevalence of HIV to drive market
                                TABLE 51 HIV TEST KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.12 HOLTER & EVENT MONITORS
                    6.3.12.1 Rising awareness of preventive care and technological advancements to drive market
                                TABLE 52 HOLTER & EVENT MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.13 DRUG & ALCOHOL TEST KITS
                    6.3.13.1 Rising consumption of drugs among teens to support market growth
                                TABLE 53 DRUG & ALCOHOL TEST KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.14 COAGULATION MONITORING PRODUCTS
                    6.3.14.1 Rising use of anticoagulant therapy and availability of home-use kits to drive market
                                TABLE 54 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.15 PEAK FLOW METERS
                    6.3.15.1 High portability and cost-efficiency to ensure adoption
                                TABLE 55 PEAK FLOW METERS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.16 COLON CANCER TEST KITS
                    6.3.16.1 High incidence of colorectal cancer to drive market growth
                                TABLE 56 COLON CANCER TEST KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.17 HOME SLEEP TESTING DEVICES
                    6.3.17.1 Cost-effectiveness of home-based sleep tests to fuel growth
                                TABLE 57 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.18 EEG DEVICES
                    6.3.18.1 Wide patient population for epilepsy to drive market for EEG devices
                                TABLE 58 EEG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.19 CHOLESTEROL TESTING PRODUCTS
                    6.3.19.1 Rising obesity levels and CVD incidence to support market
                                TABLE 59 CHOLESTEROL TESTING PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.20 HOME HEMOGLOBIN A1C TEST KITS
                    6.3.20.1 High incidence of diabetes to drive market
                                TABLE 60 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.4 MOBILITY CARE PRODUCTS
          TABLE 61 KEY MOBILITY CARE PRODUCTS AVAILABLE IN THE MARKET
          TABLE 62 MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 63 MOBILITY CARE PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.4.1 WHEELCHAIRS
                    6.4.1.1 Increased preference for wheelchairs to boost demand
                                TABLE 64 WHEELCHAIRS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.4.2 MOBILITY SCOOTERS
                    6.4.2.1 High cost to affect end-user adoption
                                TABLE 65 MOBILITY SCOOTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.4.3 WALKERS & ROLLATORS
                    6.4.3.1 Difficulties in using walkers and availability of alternatives to restrain market
                                TABLE 66 WALKERS & ROLLATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.4.4 CRUTCHES
                    6.4.4.1 High preference for axilla crutches to support demand
                                TABLE 67 CRUTCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.4.5 CANES
                    6.4.5.1 Wide usage of canes to drive market
                                TABLE 68 CANES MARKET, BY REGION, 2020–2027 (USD MILLION)

7 HOME HEALTHCARE MARKET, BY SERVICE (Page No. - 136)
    7.1 INTRODUCTION
          TABLE 69 GLOBAL MARKET, BY SERVICE, 2020–2027 (USD BILLION)
          TABLE 70 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION)
    7.2 SKILLED NURSING SERVICES
           7.2.1 SKILLED NURSING SERVICES TO DOMINATE MARKET
                    TABLE 71 SKILLED NURSING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.3 REHABILITATION THERAPY SERVICES
           7.3.1 RISING DEMAND, GROWING GERIATRIC POPULATION, AND INCREASING DISEASE INCIDENCE TO BOOST DEMAND FOR THERAPY
                    TABLE 72 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.4 HOSPICE & PALLIATIVE CARE SERVICES
           7.4.1 RISING GERIATRIC POPULATION TO DRIVE HOSPICE & PALLIATIVE CARE SERVICE DEMAND
                    TABLE 73 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.5 UNSKILLED CARE SERVICES
           7.5.1 COST-EFFECTIVENESS TO DRIVE GROWTH
                    TABLE 74 UNSKILLED SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.6 RESPIRATORY THERAPY SERVICES
           7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET
                    TABLE 75 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.7 INFUSION THERAPY SERVICES
           7.7.1 SAFETY AND EFFECTIVENESS OF HOME INFUSION TO DRIVE DEMAND
                    TABLE 76 INFUSION THERAPY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.8 PREGNANCY CARE SERVICES
           7.8.1 NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE MARKET GROWTH
                    TABLE 77 PREGNANCY CARE MARKET, BY REGION, 2020–2027 (USD MILLION)

8 HOME HEALTHCARE MARKET, BY INDICATION (Page No. - 145)
    8.1 INTRODUCTION
          TABLE 78 GLOBAL MARKET, BY INDICATION, 2020–2027 (USD BILLION)
          TABLE 79 HOME HEALTHCARE INDICATIONS MARKET, BY REGION, 2020–2027 (USD BILLION)
    8.2 CANCER
           8.2.1 CANCER TO DOMINATE INDICATIONS MARKET
                    TABLE 80 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
                    TABLE 81 GLOBAL MARKET FOR CANCER, BY REGION, 2020–2027 (USD MILLION)
    8.3 RESPIRATORY DISEASES
           8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET
                    TABLE 82 GLOBAL MARKET FOR RESPIRATORY DISEASES, BY REGION, 2020–2027 (USD MILLION)
    8.4 MOVEMENT DISORDERS
           8.4.1 GROWING GERIATRIC POPULATION TO DRIVE DEMAND FOR THERAPY EQUIPMENT
                    TABLE 83 GLOBAL MARKET FOR MOVEMENT DISORDERS, BY REGION, 2020–2027 (USD MILLION)
    8.5 CVD & HYPERTENSION
           8.5.1 RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE GROWTH
                    TABLE 84 GLOBAL MARKET FOR CVD & HYPERTENSION, BY REGION, 2020–2027 (USD MILLION)
    8.6 PREGNANCY
           8.6.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH
                    TABLE 85 GLOBAL MARKET FOR PREGNANCY, BY REGION, 2020–2027 (USD MILLION)
    8.7 WOUND CARE
           8.7.1 GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET GROWTH
                    TABLE 86 GLOBAL MARKET FOR WOUND CARE, BY REGION, 2020–2027 (USD MILLION)
    8.8 DIABETES
           8.8.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH
                    TABLE 87 GLOBAL MARKET FOR DIABETES, BY REGION, 2020–2027 (USD MILLION)
    8.9 HEARING DISORDERS
           8.9.1 WORLDWIDE INCREASE IN HEARING DISABILITIES TO ENSURE SUSTAINED GROWTH
                    TABLE 88 GLOBAL MARKET FOR HEARING DISORDERS, BY REGION, 2020–2027 (USD MILLION)
    8.10 OTHER INDICATIONS
          TABLE 89 GLOBAL MARKET FOR OTHER INDICATIONS, BY REGION, 2020–2027 (USD MILLION)

9 HOME HEALTHCARE MARKET, BY REGION (Page No. - 156)
    9.1 INTRODUCTION
          TABLE 90 GLOBAL MARKET, BY REGION, 2020–2027 (USD BILLION)
    9.2 NORTH AMERICA
          FIGURE 34 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT
          TABLE 91 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
          TABLE 92 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
          TABLE 93 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 94 NORTH AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 95 NORTH AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 96 NORTH AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 97 NORTH AMERICA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
          TABLE 98 NORTH AMERICA: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 US to dominate North American home healthcare market
                                TABLE 99 US: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 100 US: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 101 US: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 102 US: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 103 US: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 104 US: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 105 US: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising geriatric population to drive market growth
                                TABLE 106 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 107 CANADA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 108 CANADA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 109 CANADA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 110 CANADA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 111 CANADA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 112 CANADA: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
    9.3 EUROPE
          TABLE 113 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
          TABLE 114 EUROPE: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
          TABLE 115 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 116 EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 117 EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 118 EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 119 EUROPE: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
          TABLE 120 EUROPE: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany to retain market leadership in Europe
                                TABLE 121 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 122 GERMANY: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 123 GERMANY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 124 GERMANY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 125 GERMANY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 126 GERMANY: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 127 GERMANY: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Rising burden of chronic diseases to boost market growth
                                TABLE 128 UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 129 UK: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 130 UK: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 131 UK: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 132 UK: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 133 UK: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 134 UK: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Government support and initiatives taken by market players to boost market
                                TABLE 135 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 136 FRANCE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 137 FRANCE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 138 FRANCE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 139 FRANCE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 140 FRANCE: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 141 FRANCE: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Rising geriatric population and favorable government policy to drive market growth
                                TABLE 142 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 143 ITALY: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 144 ITALY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 145 ITALY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 146 ITALY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 147 ITALY: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 148 ITALY: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Rising geriatric population and incidence of chronic conditions to drive market growth
                                TABLE 149 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 150 SPAIN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 151 SPAIN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 152 SPAIN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 153 SPAIN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 154 SPAIN: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 155 SPAIN: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 156 ROE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                    TABLE 157 ROE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 158 ROE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 159 ROE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 160 ROE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 161 ROE: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 162 ROE: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
    9.4 ASIA PACIFIC
          FIGURE 35 APAC: HOME HEALTHCARE MARKET SNAPSHOT
          TABLE 163 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
          TABLE 164 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
          TABLE 165 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 166 ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 167 ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 168 ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 169 ASIA PACIFIC: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
          TABLE 170 ASIA PACIFIC: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Japan to command largest share of APAC market
                                TABLE 171 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 172 JAPAN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 173 JAPAN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 174 JAPAN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 175 JAPAN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 176 JAPAN: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 177 JAPAN: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Healthcare development and reforms to drive market growth
                                TABLE 178 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 179 CHINA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 180 CHINA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 181 CHINA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 182 CHINA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 183 CHINA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 184 CHINA: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Increasing target patient population to drive market
                                TABLE 185 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                                TABLE 186 INDIA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 187 INDIA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 188 INDIA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 189 INDIA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 190 INDIA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 191 INDIA: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 192 ROAPAC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
                    TABLE 193 ROAPAC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 194 ROAPAC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 195 ROAPAC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 196 ROAPAC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 197 ROAPAC: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 198 ROAPAC: MARKET, BY INDICATION, 2020–2027 (USD MILLION)
    9.5 REST OF THE WORLD
          TABLE 199 ROW: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)
          TABLE 200 ROW: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 201 ROW: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 202 ROW: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 203 ROW: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 204 ROW: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
          TABLE 205 ROW: MARKET, BY INDICATION, 2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 240)
     10.1 OVERVIEW
     10.2 KEY STRATEGIES ADOPTED BY PLAYERS/RIGHT TO WIN
             TABLE 206 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
             FIGURE 36 REVENUE SHARE ANALYSIS OF TOP PLAYERS
     10.4 MARKET SHARE ANALYSIS
             FIGURE 37 SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
             FIGURE 38 BLOOD GLUCOSE MONITORS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
     10.5 COMPANY EVALUATION QUADRANT (2021)
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                       FIGURE 39 HOME HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT, 2021
     10.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021)
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                       FIGURE 40 GLOBAL MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
     10.7 COMPETITIVE BENCHMARKING
             FIGURE 41 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS
             TABLE 207 GLOBAL MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
             TABLE 208 PRODUCT FOOTPRINT OF KEY PLAYERS
             TABLE 209 REGIONAL FOOTPRINT OF KEY PLAYERS
             TABLE 210 HOME HEALTHCARE MARKET: DETAILED LIST OF KEY START-UPS/SMES
     10.8 COMPETITIVE SCENARIO
             10.8.1 PRODUCT LAUNCHES
                         TABLE 211 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
             10.8.2 DEALS
                         TABLE 212 KEY DEALS
             10.8.3 OTHER DEVELOPMENTS
                         TABLE 213 OTHER KEY DEVELOPMENTS, JANUARY 2019–OCTOBER 2022

11 COMPANY PROFILES (Page No. - 253)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     11.1 KEY PLAYERS
             11.1.1 FRESENIUS
                         TABLE 214 FRESENIUS: BUSINESS OVERVIEW
                         FIGURE 42 FRESENIUS: COMPANY SNAPSHOT (2021)
                         TABLE 215 FRESENIUS: EXCHANGE RATES UTILIZED FOR CONVERSION OF EUR TO USD
                         TABLE 216 FRESENIUS: PRODUCT LAUNCHES
                         TABLE 217 FRESENIUS: DEALS
                         TABLE 218 FRESENIUS: OTHER DEVELOPMENTS
             11.1.2 LINDE
                         TABLE 219 LINDE: BUSINESS OVERVIEW
                         FIGURE 43 LINDE: COMPANY SNAPSHOT (2021)
             11.1.3 F. HOFFMANN-LA ROCHE
                         TABLE 220 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
                         FIGURE 44 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021)
                         TABLE 221 F. HOFFMANN-LA ROCHE: EXCHANGE RATES UTILIZED FOR CONVERSION OF CHF TO USD 262
                         TABLE 222 F. HOFFMANN-LA ROCHE: PRODUCT LAUNCHES & APPROVALS
                         TABLE 223 F. HOFFMANN-LA ROCHE: DEALS
             11.1.4 A&D COMPANY
                         TABLE 224 A&D COMPANY: BUSINESS OVERVIEW
                         FIGURE 45 A&D COMPANY: COMPANY SNAPSHOT (2022)
                         TABLE 225 A&D COMPANY: PRODUCT LAUNCHES
             11.1.5 INVACARE CORPORATION
                         TABLE 226 INVACARE CORPORATION: BUSINESS OVERVIEW
                         FIGURE 46 INVACARE CORPORATION: COMPANY SNAPSHOT (2021)
                         TABLE 227 INVACARE CORPORATION: PRODUCT LAUNCHES
             11.1.6 ABBOTT
                         TABLE 228 ABBOTT: BUSINESS OVERVIEW
                         FIGURE 47 ABBOTT: COMPANY SNAPSHOT (2021)
                         TABLE 229 ABBOTT: PRODUCT LAUNCHES AND PRODUCT APPROVALS
                         TABLE 230 ABBOTT: DEALS
             11.1.7 AMEDISYS
                         TABLE 231 AMEDISYS: BUSINESS OVERVIEW
                         FIGURE 48 AMEDISYS: COMPANY SNAPSHOT (2021)
                         TABLE 232 AMEDISYS: DEALS
             11.1.8 RESMED
                         TABLE 233 RESMED: BUSINESS OVERVIEW
                         FIGURE 49 RESMED: COMPANY SNAPSHOT (2022)
                         TABLE 234 RESMED: DEALS
             11.1.9 LHC GROUP
                         TABLE 235 LHC GROUP: BUSINESS OVERVIEW
                         FIGURE 50 LHC GROUP: COMPANY SNAPSHOT (2021)
                         TABLE 236 LHC GROUP: DEALS
             11.1.10 OMRON CORPORATION
                         TABLE 237 OMRON CORPORATION: BUSINESS OVERVIEW
                                                  FIGURE 51 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
                         TABLE 238 OMRON CORPORATION: EXCHANGE RATES UTILIZED FOR CONVERSION OF YEN TO USD 292
                         TABLE 239 OMRON CORPORATION: DEALS
             11.1.11 KONINKLIJKE PHILIPS
                         TABLE 240 KONINKLIJKE PHILIPS: BUSINESS OVERVIEW
                         FIGURE 52 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2021)
                         TABLE 241 KONINKLIJKE PHILIPS: EXCHANGE RATES UTILIZED FOR CONVERSION OF EUR TO USD 297
                         TABLE 242 KONINKLIJKE PHILIPS: PRODUCT/SERVICE LAUNCHES AND APPROVALS
                         TABLE 243 KONINKLIJKE PHILIPS: DEALS
             11.1.12 GE HEALTHCARE
                         TABLE 244 GE HEALTHCARE: BUSINESS OVERVIEW
                         FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
                         TABLE 245 GE HEALTHCARE: DEALS
     11.2 OTHER PLAYERS
             11.2.1 BAYADA HOME HEALTH CARE
             11.2.2 DRIVE DEVILBISS HEALTHCARE LIMITED
             11.2.3 HAMILTON MEDICAL
             11.2.4 SUNRISE MEDICAL
             11.2.5 ROMA MEDICAL
             11.2.6 CAREMAX REHABILITATION EQUIPMENT
             11.2.7 VITALOGRAPH
             11.2.8 ADVITA PFLEGEDIENST
             11.2.9 RENAFAN GMBH
             11.2.10 ADMR
             11.2.11 APEX MEDICAL CORP.
             11.2.12 CONTEC MEDICAL SYSTEMS
             11.2.13 LÖWENSTEIN MEDICAL TECHNOLOGY
             11.2.14 B. BRAUN MELSUNGEN AG
             11.2.15 BAXTER INTERNATIONAL
             11.2.16 ALLIED HEALTHCARE PRODUCTS
             11.2.17 MEDLINE INDUSTRIES
             11.2.18 ADVIN HEALTH CARE

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 323)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 CUSTOMIZATION OPTIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the home healthcare market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments' and subsegments' market sizes.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies, white papers, certified publications, articles by recognised authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organisations related to all segments of this industry's value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.

The following is a breakdown of the primary respondents:

Home Healthcare Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the home healthcare market's total size. These methods were also extensively used to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research.
  • The revenues generated by leading players operating in the home healthcare market have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Top-Down Approach

Home Healthcare Market

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size using the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, segment, and forecast the global home healthcare market by product, service, indication, and region.
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges),
  • to analyse micromarkets with respect to individual growth trends, prospects, and contributions to the overall home healthcare market.
  • to analyse market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • to forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
  • To profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies,
  • to track and analyse company developments such as product launches, agreements, partnerships, and acquisitions in the home healthcare market.
  • to benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyses market players on various parameters within the broad categories of business and product strategy.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company's specific needs. The following customization options are available for this report:

Country Information

Home healthcare market size and growth rate estimates for countries in the rest of Europe, the rest of Asia Pacific, and the rest of the world

Company profiles

Five more company profiles of players in the home healthcare market

Report Code
MD 1160
Published ON
Nov, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Home Healthcare Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback